Cargando…

Association of Glucose-Lowering Drugs With Outcomes in Patients With Diabetes Before Hospitalization for COVID-19: A Systematic Review and Network Meta-analysis

IMPORTANCE: Patients with COVID-19 have a high prevalence of diabetes, and diabetes and blood glucose control are determinants of intensive care unit admission and mortality. OBJECTIVE: To evaluate the association between COVID-19–related adverse outcomes and 8 antihyperglycemic drugs in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Zheng, Zeng, Qingya, Liu, Qinyu, Wen, Junping, Chen, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856231/ https://www.ncbi.nlm.nih.gov/pubmed/36472874 http://dx.doi.org/10.1001/jamanetworkopen.2022.44652

Ejemplares similares

ODP240 Routine Glucose-lowering Therapies and Risk of Adverse Outcomes in COVID-19 Patients with Diabetes: a Network Meta-analysis
por: Zhu, Zheng, et al.
Publicado: (2022)

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
por: Nelson, Adam J., et al.
Publicado: (2022)

Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data
por: Khunti, Kamlesh, et al.
Publicado: (2021)

Comparative efficacy and safety of glucose-lowering drugs in children and adolescents with type 2 diabetes: A systematic review and network meta-analysis
por: Wu, Sijia, et al.
Publicado: (2022)

Antibody responses to COVID‐19 vaccination in people with obesity: A systematic review and meta‐analysis
por: Ou, Xiaodan, et al.
Publicado: (2022)

Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study
por: Jørgensen, Casper H, et al.
Publicado: (2010)

The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy
por: Ye, Yicong, et al.
Publicado: (2012)

Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis
por: Qiancheng, Deng, et al.
Publicado: (2017)

Effect of adjunctive glucose-lowering drugs on body weight in people with type 1 diabetes: a systematic review and network meta-analysis protocol
por: Laugesen, Christian, et al.
Publicado: (2020)

Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis
por: Ida, Satoshi, et al.
Publicado: (2018)

Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis
por: Zhang, Da-Peng, et al.
Publicado: (2020)

Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes
por: Ko, Hwa Yeon, et al.
Publicado: (2023)

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals
por: Meloni, Alison R, et al.
Publicado: (2013)

Relationship between frailty and mortality, hospitalization, and cardiovascular diseases in diabetes: a systematic review and meta-analysis
por: Ida, Satoshi, et al.
Publicado: (2019)

Quality of Care Before and After Mergers and Acquisitions of Rural Hospitals
por: Jiang, H. Joanna, et al.
Publicado: (2021)

Association of Mechanical Bowel Preparation and Oral Antibiotics Before Elective Colorectal Surgery With Surgical Site Infection: A Network Meta-analysis
por: Toh, James W. T., et al.
Publicado: (2018)

Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997–2017: Time trends in incidence and HbA(1c) and glucose‐lowering drug use before and after hypoglycaemia
por: Bengtsen, Mads Bisgaard, et al.
Publicado: (2021)

Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2022)

Comparison of Risk Scores for Lower Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
por: Almaghrabi, Majed, et al.
Publicado: (2022)

Generalizability of sodium-glucose co-transporter-2 inhibitors cardiovascular outcome trials to the type 2 diabetes population: a systematic review and meta-analysis
por: Castellana, Marco, et al.
Publicado: (2020)

Comparison of Amitriptyline and US Food and Drug Administration–Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis
por: Farag, Hussein M., et al.
Publicado: (2022)

Social network ties before and after retirement: a cohort study
por: Kauppi, M., et al.
Publicado: (2021)

Emergency Department and Hospital Utilization Among Older Adults Before and After Identification of Elder Mistreatment
por: Rosen, Tony, et al.
Publicado: (2023)

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
por: Fei, Yue, et al.
Publicado: (2019)

Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis: A Network Meta-Analysis
por: Guski, Louise S., et al.
Publicado: (2023)

Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic
por: Bourdeau, Malou, et al.
Publicado: (2023)

Admissions for Bronchiolitis at Children’s Hospitals Before and During the COVID-19 Pandemic
por: Remien, Kailey A., et al.
Publicado: (2023)

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
por: Li, Hang-Long, et al.
Publicado: (2021)

Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agents
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Incidence of Diabetes Among Youth Before and During the COVID-19 Pandemic
por: Mefford, Matthew T., et al.
Publicado: (2023)

Injection Drug Use Frequency Before and After Take-Home Naloxone Training
por: Colledge-Frisby, Samantha, et al.
Publicado: (2023)

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
por: Salah, Husam M., et al.
Publicado: (2022)

Severe cutaneous reactions to drugs in the setting of a general hospital
por: Grando, Luciana Rosa, et al.
Publicado: (2014)

Natural Variation in the Yeast Glucose-Signaling Network Reveals a New Role for the Mig3p Transcription Factor
por: Lewis, Jeffrey A., et al.
Publicado: (2012)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography
por: Kuroda, Masaru, et al.
Publicado: (2015)

Acute cardiovascular hospitalizations and illness severity before and during the COVID‐19 pandemic
por: Rao, Vishal N., et al.
Publicado: (2021)

Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
por: Infante, Marco, et al.
Publicado: (2022)

Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures
por: Lundgren, Julie R., et al.
Publicado: (2019)

Comparative effects of lipid lowering, hypoglycemic, antihypertensive and antiplatelet medications on carotid artery intima-media thickness progression: a network meta-analysis
por: Huang, Rongzhong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ha3r8ks40mnh7rt3rv8aliggvq